VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
VBI Vaccines (VBIV) - Cash on Hand
Cash on Hand as of December 2023 : $23.68 M
According to VBI Vaccines
's latest financial reports the company has $23.68 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
VBI Vaccines - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $62.62 M | -48.54% |
| 2021-12-31 | $0.12 B | 2.18% |
| 2020-12-31 | $0.11 B | 169.38% |
| 2019-12-31 | $44.21 M | -25.4% |
| 2018-12-31 | $59.27 M | -12.44% |
| 2017-12-31 | $67.69 M | 109.7% |
| 2016-12-31 | $32.28 M | 158.75% |
| 2015-12-31 | $12.47 M | |
| 2015-03-31 | $39.42 M | 4.55% |
| 2014-03-31 | $37.71 M | -22.2% |
| 2013-03-31 | $48.47 M | -16.71% |
| 2012-03-31 | $58.19 M | 184.58% |
| 2011-03-31 | $20.44 M | 919.41% |
| 2010-03-31 | $2 M | 721.2% |
| 2009-03-31 | $0.24 M | -0.39% |
| 2008-03-31 | $0.24 M | -57.01% |
| 2007-03-31 | $0.57 M | -13.89% |
| 2006-03-31 | $0.66 M | 1175.24% |
| 2005-03-31 | $0.05 M | -74.82% |
| 2004-03-31 | $0.2 M | 161.51% |
| 2003-03-31 | $0.07 M | 966.29% |
| 2002-03-31 | $0 M | 23.6% |
| 2001-03-31 | $0 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | $20.82 M | -12.09% | 🇺🇸 USA |
 Curis CRIS | $56.33 M | 137.85% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.14 B | 494.89% | 🇺🇸 USA |